The USC Shoah Foundation is pleased to announce the addition of the first interactive biography (Dimensions in Testimony) ...
Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing technologies Alliance positions INBS to ...
Looking to create a website without code? We'll show you how to build a Wix website without learning anything about ...
Spotify has acquired the sample-sourcing website WhoSampled. The streaming service announced that it’s rolling out a new feature called SongDNA, which will aggregate and centralize samples and covers ...
Sulfur caves are among the most extreme habitats on Earth. They are completely dark and filled with hydrogen sulfide gas, which is toxic to most life-forms. Inside, species’ survival depends on ...
A giant colonial spiderweb in a sulfuric cave on the border between Greece and Albania may be the largest ever found — and it was built by spiders we didn't know liked the company of others. When you ...
One week after King Charles III initiated the formal process to remove the style, titles and honors of Prince Andrew, his brother's name was notably missing from the royal website. Buckingham Palace ...
Buckingham Palace announced on Oct. 30 that King Charles has "initiated a formal process to remove the Style, Titles and Honours" from his brother Stephanie Petit is a Royals Editor, Writer and ...
Roche may have been exploring ways to shuttle drugs to the brain for well over a decade, but that’s not stopping the pharma from handing $55 million to Manifold Bio for a fresh route through the blood ...
Tim Berners-Lee may have the smallest fame-to-impact ratio of anyone living. Strangers hardly ever recognize his face; on “Jeopardy!,” his name usually goes for at least sixteen hundred dollars.
The Insider is Venture Partners at CU Boulder's monthly newsletter featuring the latest headlines, news, events, opportunities and emerging innovations from the university. We have several editions ...
WELLESLEY HILLS, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results